BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35293340)

  • 1. Using FibroScan to Assess for the Development of Liver Fibrosis in Patients With Arthritis on Methotrexate: A Single-center Experience.
    Darabian S; Wade JP; Kur J; Wade SD; Sayre EC; Badii M
    J Rheumatol; 2022 Jun; 49(6):558-565. PubMed ID: 35293340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of liver fibrosis by Fibroscan in patients on long-term methotrexate therapy for rheumatoid arthritis.
    Bafna P; Sahoo RR; Hazarika K; Manoj M; Rungta S; Wakhlu A
    Clin Rheumatol; 2021 Sep; 40(9):3605-3613. PubMed ID: 33686476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
    Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
    Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of liver fibrosis in patients with rheumatoid arthritis treated with methotrexate: Utility of fibroscan and biochemical markers in routine clinical practice.
    de Diego-Sola A; Castiella Eguzkiza A; López Domínguez LM; Urreta Barallobre I; Sánchez Iturri MJ; Belzunegui Otaño JM; Zapata Morcillo EM;
    Reumatol Clin (Engl Ed); 2023 Oct; 19(8):412-416. PubMed ID: 37805254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between Cumulative Methotrexate Dose, Metabolic Syndrome and Hepatic Fibrosis Detected by FibroScan in Rheumatoid Arthritis Patients.
    Lertnawapan R; Chonprasertsuk S; Siramolpiwat S; Jatuworapruk K
    Medicina (Kaunas); 2023 May; 59(6):. PubMed ID: 37374233
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of liver fibrosis by transient elastography in methotrexate treated patients.
    Barbero-Villares A; Mendoza J; Trapero-Marugan M; Gonzalez-Alvaro I; Daudén E; Gisbert JP; Moreno-Otero R
    Med Clin (Barc); 2011 Nov; 137(14):637-9. PubMed ID: 21719043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of noninvasive screening tools for hepatic fibrosis, association with methotrexate cumulative dose, and risk factors in psoriasis patients.
    Lee JHM; Loo CH; Tan WC; Lee CK; Jamil A; Khor YH
    Dermatol Ther; 2022 Jan; 35(1):e15203. PubMed ID: 34779102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: A cross-sectional controlled study with real-time two-dimensional shear wave elastography.
    Erre GL; Cadoni ML; Meloni P; Castagna F; Mangoni AA; Piga M; Passiu G; Carru C; Zinellu A; Vidili G
    Eur J Intern Med; 2019 Nov; 69():57-63. PubMed ID: 31474422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Substantial Liver Fibrosis by Real-time Shear Wave Elastography in Methotrexate-Treated Patients With Rheumatoid Arthritis.
    Kim TY; Kim JY; Sohn JH; Lee HS; Bang SY; Kim Y; Kim MY; Jeong WK
    J Ultrasound Med; 2015 Sep; 34(9):1621-30. PubMed ID: 26269292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate does not increase the risk of liver fibrosis in patients with rheumatoid arthritis: assessment by ultrasound elastography (ARFI-MetRA study).
    Feuchtenberger M; Kraus L; Nigg A; Schulze-Koops H; Schäfer A
    Rheumatol Int; 2021 Jun; 41(6):1079-1087. PubMed ID: 33608744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated.
    Atallah E; Grove JI; Crooks C; Burden-Teh E; Abhishek A; Moreea S; Jordan KM; Ala A; Hutchinson D; Aspinall RJ; Murphy R; Aithal GP
    J Hepatol; 2023 May; 78(5):989-997. PubMed ID: 36702175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of liver fibrosis by transient elastography (Fibroscan®) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial.
    Barbero-Villares A; Mendoza Jiménez-Ridruejo J; Taxonera C; López-Sanromán A; Pajares R; Bermejo F; Pérez-Calle JL; Mendoza JL; Algaba A; Moreno-Otero R; Maté J; Gisbert JP;
    Scand J Gastroenterol; 2012 May; 47(5):575-9. PubMed ID: 22229701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: a case-control study.
    Laharie D; Seneschal J; Schaeverbeke T; Doutre MS; Longy-Boursier M; Pellegrin JL; Chabrun E; Villars S; Zerbib F; de Lédinghen V
    J Hepatol; 2010 Dec; 53(6):1035-40. PubMed ID: 20801541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of liver elasticity with shear-wave elastography in juvenile idiopathic arthritis patients receiving methotrexate.
    Özdemir Çiçek S; Karaman ZF; Şahin N; Paç Kısaarslan A; Poyrazoğlu MH; Düşünsel R
    Pediatr Int; 2022 Jan; 64(1):e15239. PubMed ID: 36217648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of liver fibrosis by transient elastography in rheumatoid arthritis patients treated with methotrexate.
    Park SH; Choe JY; Kim SK
    Joint Bone Spine; 2010 Dec; 77(6):588-92. PubMed ID: 20471892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of liver fibrosis markers in people with rheumatoid arthritis on methotrexate.
    Olsson-White DA; Olynyk JK; Ayonrinde OT; Paramalingam S; Keen HI
    Intern Med J; 2022 Apr; 52(4):566-573. PubMed ID: 33135387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver Fibrosis in Rheumatoid Arthritis Patients Treated with Methotrexate.
    Hilal G; Akasbi N; Boudouaya H; Salma K; Harzy T
    Curr Rheumatol Rev; 2020; 16(4):293-297. PubMed ID: 32189595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of noninvasive diagnostic procedures for assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis.
    Frankowski M; Świerkot J; Gomułkiewicz M; Korman L; Skoczyńska M; Starba A
    Rheumatol Int; 2022 Apr; 42(4):631-638. PubMed ID: 34870735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis.
    Berends MA; Snoek J; de Jong EM; Van Krieken JH; de Knegt RJ; van Oijen MG; van de Kerkhof PC; Drenth JP
    Liver Int; 2007 Jun; 27(5):639-45. PubMed ID: 17498249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn's disease patients treated with methotrexate.
    Laharie D; Zerbib F; Adhoute X; Boué-Lahorgue X; Foucher J; Castéra L; Rullier A; Bertet J; Couzigou P; Amouretti M; de Lédinghen V
    Aliment Pharmacol Ther; 2006 Jun; 23(11):1621-8. PubMed ID: 16696812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.